Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)
China · Delayed Price · Currency is CNY 39.45
+0.22 (0.56%)
Jun 18, 2026, 2:25 PM CST
SHA:688050 Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, SHA:688050 stock has a consensus rating of "Buy" and an average price target of ¥71.66. The average 1-year stock price forecast is 81.65% higher than the current stock price, while the lowest is ¥60.00 (+52.09%) and the highest is ¥90.00 (+128.14%).
Price Target: ¥71.66 (+81.65%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHA:688050 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 3 | 3 | 3 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 5 | 6 |
Financial Forecast
Revenue This Year
1.82B
from 1.48B
Increased by 22.71%
Revenue Next Year
2.17B
from 1.82B
Increased by 19.05%
EPS This Year
2.30
from 1.33
Increased by 72.99%
EPS Next Year
2.67
from 2.30
Increased by 16.15%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.9B | ||
| Avg | 1.8B | ||
| Low | 1.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 27.5% | ||
| Avg | 22.7% | ||
| Low | 12.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 2.30 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 73.0% | ||
| Low | - |